ArticleJournal of breast cancer2024

Metformin Alters Tumor Immune Microenvironment, Improving the Outcomes of Breast Cancer Patients With Type 2 Diabetes Mellitus.

Satomi Shiba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.